Kvutsat Shiller, Israel

Asi Haviv

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Asi Haviv: Innovator in Pharmaceutical Treatments

Introduction

Asi Haviv is a notable inventor based in Kvutsat Shiller, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of chronic diseases. With a total of 3 patents to his name, Haviv's work focuses on innovative methods to improve patient outcomes.

Latest Patents

Haviv's latest patents include groundbreaking methods for treating Crohn's disease and lupus nephritis. One of his patents details the use of laquinimod for treating Crohn's disease patients who have failed first-line anti-TNF therapy. This application outlines a method for administering laquinimod to patients afflicted with anti-TNFα refractory Crohn's disease, as well as those with non-fibrostenotic Crohn's disease. The method involves periodic administration of an effective amount of laquinimod, specifically less than 0.5 mg/day, to induce or maintain clinical remission.

Another significant patent focuses on the treatment of lupus nephritis using laquinimod. This invention provides a method for administering laquinimod to subjects afflicted with active lupus nephritis, ensuring effective treatment through a pharmaceutical composition that includes laquinimod or its pharmaceutically acceptable salts.

Career Highlights

Asi Haviv is currently associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to contribute to the development of innovative treatments that address unmet medical needs.

Collaborations

Haviv collaborates with talented professionals in the field, including Nora Tarcic and Eran Blaugrund. These collaborations enhance the research and development efforts at Teva, fostering an environment of innovation.

Conclusion

Asi Haviv's contributions to pharmaceutical innovations, particularly in the treatment of Crohn's disease and lupus nephritis, highlight his role as a significant inventor in the industry. His work continues to impact patient care positively, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…